triazoles has been researched along with Lennox-Gastaut Syndrome in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 25 (69.44) | 24.3611 |
| 2020's | 11 (30.56) | 2.80 |
| Authors | Studies |
|---|---|
| García-Peñas, JJ; Gil Nagel-Rein, A; Sánchez-Carpintero, R; Villanueva-Haba, V | 1 |
| Wang, C; Wang, J; Zhang, L | 1 |
| Chez, M; Dixon-Salazar, T; Flamini, JR; Hyslop, A; McGoldrick, P; Millichap, JJ; Pina-Garza, JE; Resnick, T; Rho, JM; Sankar, R; Wolf, S | 1 |
| Bozarth, XL; Oesch, G | 1 |
| Caraballo, RH; Espeche, A; Fasulo, L; Galichio, S; Pociecha, J; Reyes, G; Semprino, M | 1 |
| Auvin, S | 1 |
| Aboumatar, S; Burdette, D; Chung, S; Kothare, S; Kuzniecky, R; Montouris, G; Rosenfeld, W | 1 |
| Città, S; Ciuffini, R; Coppola, G; Elia, M; Manfredi, V; Marrelli, A; Operto, FF; Pastorino, GMG; Sole, M; Striano, P; Verrotti, A; Zucca, C | 1 |
| Chou, P; Hsueh, SW; Huang, CS; Kuo, CC; Lai, YC; Lin, TH; Lin, YC; Wang, RW; Yang, YC | 1 |
| Brigo, F; Eltze, C; Jones, K; Matricardi, S | 1 |
| Dawman, L; Panda, P; Panda, PK; Sharawat, IK | 1 |
| Auvin, S; Brandt, C; McMurray, R; Nikanorova, M | 1 |
| Falip, M; McMurray, R; Santamarina, E; Striano, P | 1 |
| Minagawa, K; Takayama, R; Watanabe, T | 1 |
| Takahashi, Y; Takayama, R; Tsukamoto, K | 1 |
| Kang, HC; Kim, HD; Kim, SH; Lee, JS | 1 |
| Arzimanoglou, A; Bibbiani, F; Dhadda, S; Ferreira, J; Kumar, D; Olhaye, O; Satlin, A | 1 |
| Chanda, K; M M, B; Maiti, B | 1 |
| Chae, JH; Choi, JE; Hwang, YS; Kim, KJ; Kim, SH; Lee, JH; Lim, BC; Ryu, HW | 1 |
| Della Bona, ML; Falchi, M; Guerrini, R; la Marca, G; Malvagia, S; Pellacani, S; Rosati, A | 1 |
| Iyoda, K; Ohtsuka, Y; Shirasaka, Y; Takano, H; Takayama, R; Yoshinaga, H | 2 |
| Cnaan, A; Dlugos, DJ; Kessler, SK; McCarthy, A | 1 |
| Arzimanoglou, A; Bibbiani, F; Critchley, D; Dhadda, S; Ferreira, JA; Hussein, Z; Kumar, D; Mendes, S; Satlin, A; Schuck, E; Williams, B | 1 |
| Becerra, JL; Burcet, J; Cano, A; Falip, M; Fernández, S; Fossas, P; Jaraba, S; Miravet, E; Miró, J; Molins, A; Pico, G; Raspall, M; Santamarina, E; Toledo, M | 1 |
| Bibbiani, F; Kluger, G; Kothare, S; Olhaye, O; Perdomo, C; Sachdeo, R; Williams, B | 1 |
| Balestri, A; Capovilla, G; Coppola, G; Curatolo, P; Fels, A; Franzoni, E; Grosso, S; Habetswallner, F; Mangano, S; Parisi, P; Pascotto, A; Spalice, A; Veggiotti, P; Verrotti, A; Zamponi, N | 1 |
| Besag, FM | 1 |
| Cerna, A; So, TY; Wier, HA | 1 |
| Boor, R; Brandt, C; Jürgens, U; Korn-Merker, E; May, TW; Rambeck, B | 1 |
| Arzimanoglou, A; Brown, LW; Flamini, R; Harrison, M; Kerr, M; Kluger, G; Kothare, S; Narurkar, M; Philip, S; Resnick, T | 1 |
| Antzelevitch, C; Borggrefe, M; Brandt, C; Ebner, A; Göksu, T; Kuschyk, J; Papavassiliu, T; Rudic, B; Schimpf, R; Veltmann, C; Wolpert, C | 1 |
| McCormack, PL | 1 |
| Byeon, JH; Eun, BL; Eun, SH; Kang, HC; Kim, HD; Kim, SH; Kwon, EJ; Lee, JS; Lee, YM | 1 |
| Capuano, A; Curatolo, P; Cusmai, R; Fusco, L; Moavero, R; Specchio, N; Vigevano, F | 1 |
| Ko, TS; Lee, EH; Yum, MS | 1 |
13 review(s) available for triazoles and Lennox-Gastaut Syndrome
| Article | Year |
|---|---|
Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
Topics: Anticonvulsants; Cannabidiol; Clobazam; Clonazepam; Diazepam; Dioxolanes; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Phenobarbital; Practice Guidelines as Topic; Pyrrolidinones; Spain; Triazoles; Valproic Acid | 2021 |
Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
Topics: Anticonvulsants; Cannabidiol; Child; Humans; Lennox Gastaut Syndrome; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Triazoles | 2022 |
Proposed anti-seizure medication combinations with rufinamide in the treatment of Lennox-Gastaut syndrome: Narrative review and expert opinion.
Topics: Anticonvulsants; Child, Preschool; Clobazam; Expert Testimony; Humans; Lennox Gastaut Syndrome; Triazoles | 2023 |
Lennox-Gastaut syndrome: New treatments and treatments under investigation.
Topics: Anticonvulsants; Cannabidiol; Drug Development; Drugs, Investigational; Fenfluramine; Humans; Lennox Gastaut Syndrome; Nitriles; Pyridones; Therapies, Investigational; Triazoles | 2020 |
Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.
Topics: Algorithms; Anticonvulsants; Clinical Trials as Topic; Clobazam; Electroencephalography; Expert Testimony; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Sleep; Triazoles | 2020 |
Anti-seizure medications for Lennox-Gastaut syndrome.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Cannabidiol; Child; Child, Preschool; Cinnamates; Clobazam; Electroencephalography; Felbamate; Humans; Lamotrigine; Lennox Gastaut Syndrome; Middle Aged; Placebos; Randomized Controlled Trials as Topic; Topiramate; Triazoles; Wakefulness; Young Adult | 2021 |
Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Topics: Anticonvulsants; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Seizures; Triazoles | 2021 |
Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Lennox Gastaut Syndrome; Outcome Assessment, Health Care; Triazoles; Young Adult | 2018 |
Dosing considerations for rufinamide in patients with Lennox-Gastaut syndrome: Phase III trial results and real-world clinical data.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Clinical Trials, Phase III as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles; Young Adult | 2017 |
Rufinamide for the treatment of Lennox-Gastaut syndrome.
Topics: Biological Availability; Double-Blind Method; Electroencephalography; Half-Life; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Placebos; Quality of Life; Randomized Controlled Trials as Topic; Spasms, Infantile; Triazoles | 2011 |
Rufinamide for pediatric patients with Lennox-Gastaut syndrome: a comprehensive overview.
Topics: Animals; Child; Epilepsies, Partial; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Spasms, Infantile; Treatment Outcome; Triazoles | 2011 |
Rufinamide from clinical trials to clinical practice in the United States and Europe.
Topics: Anticonvulsants; Child; Child, Preschool; Europe; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Randomized Controlled Trials as Topic; Seizures; Spasms, Infantile; Treatment Outcome; Triazoles; United States | 2011 |
Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
Topics: Administration, Oral; Anticonvulsants; Cost-Benefit Analysis; Economics, Pharmaceutical; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Models, Economic; Quality-Adjusted Life Years; Spasms, Infantile; Triazoles; United Kingdom | 2012 |
9 trial(s) available for triazoles and Lennox-Gastaut Syndrome
| Article | Year |
|---|---|
Real-world data on rufinamide treatment in patients with Lennox-Gastaut syndrome: Results from a European noninterventional registry study.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Ethnicity; Europe; European Union; Female; Humans; Lennox Gastaut Syndrome; Male; Registries; Seizures; Sleep Stages; Treatment Outcome; Triazoles | 2017 |
Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303.
Topics: Anticonvulsants; Child; Child, Preschool; Female; Humans; Lennox Gastaut Syndrome; Male; Triazoles | 2019 |
A pharmacokinetic study and correlation with clinical response of rufinamide in infants with epileptic encephalopathies.
Topics: Anticonvulsants; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Intellectual Disability; Lennox Gastaut Syndrome; Male; Spasms, Infantile; Triazoles | 2013 |
Rufinamide as an adjunctive therapy for Lennox-Gastaut syndrome: a randomized double-blind placebo-controlled trial in Japan.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Electroencephalography; Female; Follow-Up Studies; Humans; Japan; Lennox Gastaut Syndrome; Male; Statistics, Nonparametric; Treatment Outcome; Triazoles; Young Adult | 2014 |
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.
Topics: Anticonvulsants; Child, Preschool; Female; Humans; Infant; Lennox Gastaut Syndrome; Male; Triazoles | 2016 |
Long-term safety and seizure outcome in Japanese patients with Lennox-Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial.
Topics: Anticonvulsants; Child; Child, Preschool; Double-Blind Method; Electrocardiography; Female; Humans; Japan; Lennox Gastaut Syndrome; Longitudinal Studies; Male; Time Factors; Treatment Outcome; Triazoles | 2016 |
Rufinamide in children and adults with Lennox-Gastaut syndrome: first Italian multicenter experience.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Italy; Lennox Gastaut Syndrome; Male; Spasms, Infantile; Treatment Outcome; Triazoles; Valproic Acid; Young Adult | 2010 |
Rufinamide as an adjuvant treatment in children with Lennox-Gastaut syndrome.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Intellectual Disability; Lennox Gastaut Syndrome; Male; Spasms, Infantile; Triazoles | 2012 |
Rufinamide efficacy and safety as adjunctive treatment in children with focal drug resistant epilepsy: the first Italian prospective study.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Intellectual Disability; Italy; Lennox Gastaut Syndrome; Male; Prospective Studies; Spasms, Infantile; Treatment Outcome; Triazoles; Young Adult | 2012 |
14 other study(ies) available for triazoles and Lennox-Gastaut Syndrome
| Article | Year |
|---|---|
Rufinamide efficacy and association with phenotype and genotype in children with intractable epilepsy: A retrospective single center study.
Topics: Anticonvulsants; Child; Child, Preschool; Drug Resistant Epilepsy; Epilepsy; Female; Genotype; Humans; Infant; Lennox Gastaut Syndrome; Male; Phenotype; Retrospective Studies; Seizures; Triazoles | 2020 |
Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.
Topics: Adolescent; Anticonvulsants; Argentina; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy; Female; Follow-Up Studies; Humans; Lennox Gastaut Syndrome; Male; Retrospective Studies; Seizures; Triazoles; Valproic Acid | 2020 |
Cognitive, adaptive, and behavioral effects of adjunctive rufinamide in Lennox-Gastaut syndrome: A prospective observational clinical study.
Topics: Adolescent; Adult; Anticonvulsants; Child; Cognition; Humans; Lennox Gastaut Syndrome; Middle Aged; Prospective Studies; Triazoles; Young Adult | 2020 |
How Can an Na
Topics: Animals; Female; Lennox Gastaut Syndrome; Male; Mice; Mice, Inbred C57BL; Neurons; Seizures; Triazoles; Voltage-Gated Sodium Channel Blockers | 2021 |
Short-term efficacy and safety of rufinamide for Lennox-Gastaut syndrome.
Topics: Anticonvulsants; Child; Female; Humans; Lennox Gastaut Syndrome; Male; Pedigree; Triazoles | 2016 |
Three children with Lennox-Gastaut syndrome presenting long-term good seizure outcome under rufinamide treatment.
Topics: Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Lennox Gastaut Syndrome; Male; Seizures; Time Factors; Treatment Outcome; Triazoles | 2017 |
Rufinamide efficacy and safety in children aged 1-4 years with Lennox-Gastaut syndrome.
Topics: Adjuvants, Pharmaceutic; Anticonvulsants; Child, Preschool; Female; Humans; Infant; Lennox Gastaut Syndrome; Male; Outcome Assessment, Health Care; Retrospective Studies; Triazoles | 2018 |
Evaluation of WO2014121383 A1: a process for preparation of rufinamide and intermediates.
Topics: Animals; Anticonvulsants; Child; Humans; Lennox Gastaut Syndrome; Patents as Topic; Triazoles | 2019 |
Short-term efficacy and tolerability of rufinamide adjunctive therapy in children with refractory generalised epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Epilepsies, Myoclonic; Epilepsy, Generalized; Female; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Spasms, Infantile; Treatment Outcome; Triazoles | 2013 |
Retention rates of rufinamide in pediatric epilepsy patients with and without Lennox-Gastaut Syndrome.
Topics: Adolescent; Anticonvulsants; Child; Cohort Studies; Epilepsy; Female; Humans; Kaplan-Meier Estimate; Lennox Gastaut Syndrome; Male; Treatment Outcome; Triazoles | 2015 |
Rufinamide in children and adults in routine clinical practice.
Topics: Adolescent; Adult; Anticonvulsants; Child; Epilepsy, Generalized; Female; Humans; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Triazoles; Vomiting; Weight Loss | 2017 |
Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Middle Aged; Seizures; Spasms, Infantile; Triazoles; Valproic Acid; Young Adult | 2011 |
Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide.
Topics: Administration, Oral; Adult; Aged; Anticonvulsants; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Electrocardiography; Epilepsy; Female; Follow-Up Studies; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Middle Aged; Spasms, Infantile; Triazoles; Young Adult | 2012 |
Effectiveness and tolerability of rufinamide in children and young adults with Lennox-Gastaut syndrome: a single center study in Korea.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Electroencephalography; Female; Humans; Intellectual Disability; Lennox Gastaut Syndrome; Male; Neurosurgical Procedures; Republic of Korea; Retrospective Studies; Seizures; Spasms, Infantile; Treatment Outcome; Triazoles; Young Adult | 2013 |